Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in Louisiana, automatically classified by Maddy, our AI policy reader.

Total bills
247
2026 Regular Session
Top supporter
Brian Glorioso
91% support rate
Top opponent
Sidney Barthelemy
38% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in Louisiana

Legislators moving healthcare in Louisiana
Legislator Party Stance Support rate Votes
Brian Glorioso
Brian Glorioso House · District 90
R
Strong +
91% 83
Jack McFarland
Jack McFarland House · District 13
R
Strong +
89% 63
Barbara Freiberg
Barbara Freiberg House · District 70
R
Strong +
88% 92
Francis Thompson
Francis Thompson House · District 19
R
Strong +
88% 60
Jeff Wiley
Jeff Wiley House · District 81
R
Strong +
85% 79
SB
Sidney Barthelemy Senate · District 3
D
Oppose
38% 31
Royce Duplessis
Royce Duplessis Senate · District 5
D
Oppose
40% 35
Dodie Horton
Dodie Horton House · District 9
R
Mixed −
43% 88
Raymond Crews
Raymond Crews House · District 8
R
Mixed −
44% 88
Jimmy Harris
Jimmy Harris Senate · District 4
D
Mixed −
45% 35
Showing 211–220 of 247 bills

All healthcare bills

signed · Louisiana · House Jun 8, 2026

HB 895: HEALTH/MEDICAL TREATMENT: Provides relative to the treatment of sexual assault survivors by hospitals and healthcare providers (EN NO IMPACT See Note)

HB 895 requires Louisiana hospitals and healthcare providers to offer sexual assault survivors specific medical treatments without undue delay. It mandates that providers make emergency contraception available and provide at least a three-day supply of HIV/STI prevention medication when medically needed, alongside private examinations adapted to each survivor's needs. The bill also requires hospitals to offer a survivor advocate (with confidential communications) during forensic exams, with the survivor's consent. This directly affects sexual assault survivors receiving emergency medical care in Louisiana hospitals.
Sub-Topics Women's Health
passed · Louisiana · House Apr 1, 2026

HB 919: INSURANCE/HEALTH: Provides relative to pharmacy benefit managers (RE +$238,163 SG EX See Note)

HB 919 requires pharmacy benefit managers (PBMs) in Louisiana to reimburse pharmacies at least the National Average Drug Acquisition Cost (NADAC) plus the state's professional dispensing fee per prescription, with a minimum $12 per prescription. It prohibits PBMs from owning or contracting with pharmacies (including subsidiaries) and mandates annual transparency reports detailing foreign subsidiaries and financial arrangements with drug manufacturers. PBMs violating these rules face fines up to $100,000 per violation for executives, with unlimited liability for large PBMs ($500M+ revenue). The law applies retroactively to prescriptions filled between January 1, 2025, and December 1, 2025, and becomes fully effective for new requirements in 2027. These provisions directly affect pharmacies, pharmacists, and PBMs operating in Louisiana.
Sub-Topics Prescription Drugs
signed · Louisiana · Senate May 15, 2026

SB 195: HEALTH CARE: Provides relative to the administration of medications. (8/1/26)

SB 195, the "Danny's Dose EMS Treatment Act," allows licensed EMTs, advanced EMTs, and paramedics to administer a patient's own time-critical prescription medications during emergencies. It specifically applies to patients with rare diseases, chronic illnesses, or special medical needs who request it, using only intranasal, intravenous, or intramuscular medications. The bill establishes commission protocols for this practice and grants immunity from liability for EMTs unless gross negligence occurs. This directly affects emergency medical personnel and patients requiring immediate access to their prescribed medications outside standard hospital settings.
Sub-Topics Hospitals
in committee · Louisiana · Senate Mar 9, 2026

SB 381: HEALTH/ACC INSURANCE: Provides for pharmacy benefit managers. (gov sig)

SB 381 (Louisiana) regulates pharmacy benefit managers (PBMs) by requiring them to pass all drug manufacturer rebates directly to health plans as lower premiums or reduced patient costs, rather than keeping them. It prohibits PBMs from withholding rebates to exclude generic or cheaper drugs from formularies and bans requiring patients to use more expensive brand-name drugs when cheaper alternatives exist. The bill also mandates a 60-day transition period for patients when a drug is removed from a formulary, ensuring continuity of care during plan changes. These provisions directly affect PBMs, health insurers, pharmacies, and patients in Louisiana by increasing transparency and reducing out-of-pocket costs. The bill is pending legislative action as of its prefiling date.
in committee · Louisiana · Senate Mar 9, 2026

SB 245: MENTAL HEALTH: Provides relative to treatments for veterans. (8/1/26) (OR SEE FISC NOTE GF EX)

SB 245 requires the Louisiana Department of Health to create a comprehensive veteran suicide prevention plan by January 1, 2027. The plan must connect veterans to ongoing, barrier-free mental health care and use non-traditional methods to rapidly address PTSD symptoms. It directly affects Louisiana veterans by mandating a state-led strategy focused on preventing suicide through collaborative, accessible services. The bill does not change existing laws but sets a deadline for the Department of Health to develop this specific prevention framework.
in committee · Louisiana · House Apr 27, 2026

HB 884: CRIMINAL/VICTIMS: Provides relative to survivors of sexually-oriented criminal offenses

HB 884 creates a Louisiana Sexual Assault Oversight Commission within the Department of Justice, requiring it to include a member with expertise in forensic medical exams for sexual assault victims. The bill mandates the Louisiana State Police Crime Laboratory to report by March 1, 2015, on untested sexual assault kits and agencies failing to submit required reports, while defining key terms like "forensic medical examination." It also requires all licensed hospitals and healthcare providers to inform sexual assault survivors about treatment options and follow specific care procedures. This bill directly affects sexual assault survivors, healthcare providers, and criminal justice agencies by improving oversight, reporting transparency, and access to care for victims.
in committee · Louisiana · House Mar 9, 2026

HB 197: HEALTH CARE/PROVIDERS: Provides for the use of artificial intelligence by healthcare providers

HB 197 establishes rules for Louisiana healthcare providers using artificial intelligence (AI). It allows AI for administrative tasks like scheduling, billing, and analyzing de-identified patient data, but prohibits AI from making treatment decisions, interacting directly with patients, or creating therapy plans without review by a licensed healthcare professional. Violations can result in civil penalties up to $10,000 per incident, with the Louisiana Department of Health empowered to investigate complaints and enforce rules. The bill directly affects all healthcare providers licensed in Louisiana who use AI tools in their practice.
in committee · Louisiana · House Mar 9, 2026

HB 277: DRUGS/PRESCRIPTION: Requires educational or marketing materials for prescription drugs directed to healthcare providers to include price information (OR SEE FISC NOTE GF EX)

HB 277 requires drug manufacturers and marketers to include specific price information in educational or promotional materials provided to healthcare providers. The bill mandates that these materials disclose the average wholesale cost for a 30-day supply (or adjusted duration for shorter treatments) and whether a biosimilar or generic alternative exists for the same condition. This directly affects pharmaceutical companies and marketing entities targeting doctors. Violations would be enforced under Louisiana’s consumer protection laws, but the bill does not regulate actual drug prices or require discounts.
Sub-Topics Prescription Drugs
signed · Louisiana · Senate Jun 12, 2026

SB 387: HEALTH/ACC INSURANCE: Provides relative to pharmacy benefit managers. (1/1/27) (EN INCREASE SG EX See Note)

SB 387 amends Louisiana law to regulate pharmacy benefit managers (PBMs), directly affecting PBMs, local pharmacies, health insurers, and patients. It establishes new definitions (like "Maximum Allowable Cost List" and "Effective rate pricing"), requires PBMs to provide transparent compensation and services to enrollees and providers, and creates a private right to sue for violations. The bill also mandates audits of PBM practices, sets penalties for noncompliance, and repeals outdated provisions. These changes aim to increase transparency and accountability in how PBMs handle prescription drug pricing and reimbursements within Louisiana.
Sub-Topics Prescription Drugs
signed · Louisiana · House Jun 25, 2026

HB 732: MTR VEHICLE/OFFICE: Provides for a temporary waiver of fees for final delinquent debt based on special circumstances (EN DECREASE SG RV See Note)

HB 732 allows Louisiana's Motor Vehicle Office to temporarily waive outstanding fees, fines, or license suspensions for up to 30 days when a person needs immediate access to life-sustaining medical treatment due to a life-threatening condition. It directly affects individuals with delinquent debt to the Motor Vehicle Office who provide documentation from a licensed physician or medical provider verifying the emergency. The bill requires the office to issue a written decision for each waiver and specifies that the temporary suspension does not forgive the underlying debt, though the commissioner may still reduce or eliminate the obligation at their discretion. This change takes effect upon gubernatorial approval or legislative override of a veto.
Showing 211 to 220 of 247 bills
Previous 1 21 22 23 25 Next